There are 2867 resources available
Conclusions and perspectives
Presenter: Rosa Giuliani
Session: The enigma of public policy in oncology: ESMO at the forefront
Resources:
Webcast
Invited Discussant LBA4, LBA5, LBA6, LBA7 - The medical oncologist point of view
Presenter: James Larkin
Session: Presidential Symposium II
Resources:
Slides
Webcast
1660O - Dual immune checkpoint blockade induces analogous alterations in the intratumoral CD8+ T cell and Treg compartments
Presenter: Joleen Traets
Session: Proffered Paper session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
529MO - Phase II study of olaparib plus durvalumab with or without bevacizumab (MEDIOLA): Final analysis of overall survival in patients with non-germline BRCA-mutated platinum-sensitive relapsed ovarian cancer
Presenter: Susana Banerjee
Session: Mini Oral session 2: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: The enigma of public policy in oncology: ESMO at the forefront
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Presidential Symposium II
Resources:
Slides
Webcast
Invited Discussant 527MO, 528MO and 529MO
Presenter: Antonio Jose Gonzalez Martin
Session: Mini Oral session 2: Gynaecological cancers
Resources:
Slides
Webcast
67O - Quantifying poly(ADP-Ribose) polymerase (PARP1) in vivo using a non-invasive PARP1 PET tracer
Presenter: Lilie Lin
Session: Proffered Paper session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
Invited Discussant 1660O and 67O
Presenter: Sandra Demaria
Session: Proffered Paper session: Basic science & translational research
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Basic science & translational research
Resources:
Slides
Webcast